Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rectal Prolapse With ODS. STARR vs LVR.
NCT04892108
Laparoscopic Ventral Mesh Rectopexy Combined With or Without Stapled Trans-anal Rectal Resection for Obstructed Defecation Syndrome
NCT03060330
International Multicenter Prospective Transtar Registry
NCT00909116
Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?
NCT02052063
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
NCT00256984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
STARR
STARR
Group B
Laparoscopic ventral Rectopexy
Laparoscopic Ventral Rectopexy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STARR
Laparoscopic Ventral Rectopexy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic rectal Intussusception and/or defecographic finding of rectocele\>2 cm
* Failure of at least 6 months of medical therapy
* Exclusion of neoplasm by rectosigmoidoscopy/colonoscopy
Exclusion Criteria
* Patients affected by slow transit constipation
* Patients affected by anismus
* Patients affected by pelvic organ prolapse
* Patients with previous rectal or anal surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bologna
OTHER
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dajana Cuicchi
Dr Dajana Cuicchi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Bologna, Bologna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-REST
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.